23andMe Buys Telehealth Provider Lemonaid for $400M
Originally conceived for users to learn about genetic characteristics, 23andMe has been moving into therapeutics.
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.